Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Question

From the College  |  Issue: September 2008  |  September 1, 2008

A 46-year-old male with osteoarthritis of his right knee comes in for a routine follow-up visit. He received an intraarticular corticosteroid injection of his right knee six weeks ago, with reported improvement in knee pain and stiffness. During follow-up, the patient reports to the nurse that he has stiffness in the knee lasting five to 10 minutes after long car rides, as well as in the morning one to two times per week. He reports mild knee pain with climbing stairs, but has no other complaints and no co-morbidities. The patient is currently on etodoloc and ranitidine as needed.

On examination, the patient has normal vital signs, height of 5’10”, weight of 190 lbs, and a body mass index of 27.3. His lungs sound clear, and his heart has regular rate and rhythm with no murmurs or friction rubs. The abdomen is soft, nontender, and has no mass or hepatosplenomegaly. The right knee has crepitus and mild tenderness on extreme of flexion, but no warmth or effusion. The left knee is unremarkable with full range of motion and no tenderness.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Diagnosis: Osteoarthritis of the right knee, clinically stable.

Plan: The patient is given prescriptions to continue etodolac and ranitidine and is counseled regarding benefits of daily exercise and weight loss in the management of osteoarthritis. Ways to incorporate daily physical activity into his schedule are discussed, along with recommendations to reduce fat and caloric intake. The patient is requested to return in four months for a follow-up appointment, or sooner if problems arise.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

What is wrong with this documentation?

Click here for the answer.

Share: 

Filed under:Billing/CodingFrom the CollegePractice Support Tagged with:BillingCodingDiagnosisOsteoarthritis

Related Articles

    Exercise Therapy Recommended to Manage Knee Osteoarthritis

    July 12, 2016

    The benefits of exercise therapy for individuals with knee osteoarthritis (OA) are well known. The ACR strongly recommends both aquatic exercise and land-based aerobic and resistance exercise for managing knee OA.1 A recent Cochrane systematic review and meta-analysis concluded that high-quality evidence supports the use of exercise to reduce pain and improve physical function and…

    Changing Our Thinking on Osteoarthritis

    March 1, 2010

    It’s time we changed our thinking on osteoarthritis

    Basics of Biologic Joint Reconstruction

    April 6, 2012

    For young patients especially, this can delay knee replacement and provide better outcomes.

    Baricitinib Studied as Possible COVID-19 Treatment; Plus Ranitidine Removed from U.S. Market

    May 11, 2020

    Baricitinib, an oral JAK1/JAK2 inhibitor approved to treat RA in adults, is being investigated as a possible treatment for hospitalized patients with COVID-19…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences